Biological roles and therapeutic potential of hydroxy-carboxylic acid receptors

Frontiers in Endocrinology

Volumn 2, Issue OCT, 2011, Pages

  Ahmed, Kashan ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

3 hydroxy octanoic acid; Deorphanization; G protein coupled receptors; GPR109a; GPR109b; GPR81; Hydroxy carboxylic acid receptors; Lactate; Nicotinic acid

Indexed keywords

EID: 84874361881     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00051     Document Type: Review

References (91)

1. Ahmed, K., Tunaru, S., Langhans, C. D., Hanson, J., Michalski, C. W., Kolker, S., Jones, P. M., Okun, J. G., and Offermanns, S. (2009a). Deorpha-nization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J. Biol. Chem. 284, 21928-21933.
2. Ahmed, K., Tunaru, S., and Offermanns, S. (2009b). GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol. Sci. 30, 557-562.
3. Ahmed, K., Tunaru, S., and Offermanns, S. (2009c). GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends Pharmacol. Sci. 30, 557-562.
4. Ahmed, K., Tunaru, S., Tang, C., Muller,M., Gille, A., Sassmann,A., Hanson, J., and Offermanns, S. (2010). An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell Metab. 11, 311-319.
5. Aktories, K., Schultz, G., and Jakobs, K. H. (1983). Islet-activating protein prevents nicotinic acid-induced GTPase stimulation and GTP but not GTP gamma S-induced adenylate cyclase inhibition in rat adipocytes. FEBS Lett. 156, 88-92.
6. Benyo, Z., Gille, A., Bennett, C. L., Clausen, B. E., and Offermanns, S. (2006). Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol. Pharmacol. 70, 1844-1849.
7. Benyo, Z., Gille, A., Kero, J., Csiky, M., Suchankova, M. C., Nusing, R. M., Moers, A., Pfeffer, K., and Offermanns, S. (2005). GPR109A(PUMA-G/HM74A) mediates nico-tinic acid-induced flushing. J. Clin. Invest. 115, 3634-3640.
8. Bermudez, Y., Benavente, C. A., Meyer, R. G., Coyle, W. R., Jacobson, M. K., and Jacobson, E. L. (2011). Nicotinic Acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS ONE 6, e20487. doi:10.1371/journal.pone.0020487
9. Boatman, P. D., Richman, J. G., and Semple, G. (2008). Nicotinic acid receptor agonists. J. Med. Chem. 51, 7653-7662.
10. Boyd, A. E., 3rd, Giamber, S. R., Mager, M., and Lebovitz, H. E. (1974). Lac-tate inhibition of lipolysis in exercising man. Metab. Clin. Exp. 23, 531-542.
11. Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K.,Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., Murdock, P. R., Sauls, H. R. Jr., Shabon, U., Spinage, L. D., Strum, J. C., Szekeres, P. G., Tan, K. B., Way, J. M., Ignar, D. M., Wilson, S., and Muir, A. I. (2003). The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278, 11303-11311.
12. Brooks, G. A., and Mercier, J. (1994). Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. J. Appl. Physiol. 76, 2253-2261.
13. Brown, A. J., Goldsworthy, S. M., Barnes,A. A., Eilert,M. M., Tcheang, L., Daniels, D., Muir, A. I., Wig-glesworth, M. J., Kinghorn, I., Fraser, N. J., Pike, N. B., Strum, J. C., Steplewski, K. M., Murdock, P. R.,Holder, J. C., Marshall, F. H., Szek-eres, P. G., Wilson, S., Ignar, D. M., Foord, S. M., Wise, A., and Dowell, S. J. (2003). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by pro-pionate and other short chain car-boxylic acids. J. Biol. Chem. 278, 11312-11319.
14. Brown, B. G., Zhao, X. Q., Chait, A., Fisher,L. D.,Cheung, M. C., Morse,J. S., Dowdy, A. A., Marino, E. K., Bol-son, E. L., Alaupovic, P., Frohlich, J., and Albers, J. J. (2001). Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 345, 1583-1592.
15. Cahill, G. F. Jr. (2006). Fuel metabolism in starvation. Annu. Rev. Nutr. 26, 1-22.
16. Cai, T. Q., Ren, N., Jin, L., Cheng, K., Kash, S., Chen, R., Wright, S. D., Taggart, A. K., and Waters, M. G. (2008). Role of GPR81 in lactate-mediated reduction of adipose lipol-ysis. Biochem. Biophys. Res. Com-mun. 377, 987-991.
17. Capuzzi, D. M., Guyton, J. R., Morgan, J. M., Goldberg, A. C., Kreis-berg, R. A., Brusco, O. A., and Brody, J. (1998). Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am. J. Cardiol. 82, 74U-81U; discussion 85U-86U.
18. Carlson,L. A. (2005). Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J. Intern. Med. 258, 94-114.
19. Cheng, K., Wu, T. J., Wu, K. K., Sturino, C., Metters, K., Gottesdiener, K., Wright, S. D., Wang, Z., O'Neill, G., Lai, E., and Waters, M. G. (2006). Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 103, 6682-6687.
20. Costa, C. G., Dorland, L., Holwerda, U., de Almeida, I. T., Poll-The, B. T., Jakobs, C., and Duran, M. (1998). Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders. Clin. Chem. 44, 463-471.
21. Covington, D. K., Briscoe, C. A., Brown, A. J., and Jayawickreme,C. K. (2006). The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem. Soc. Trans. 34, 770-773.
22. DiGirolamo, M., Newby, F. D., and Lovejoy, J. (1992). Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J. 6, 2405-2412.
23. Drews, J. (2000). Drug discovery: a historical perspective. Science 287, 1960-1964.
24. Duncan, R. E., Ahmadian, M., Jaworski, K., Sarkadi-Nagy, E., and Sul, H. S. (2007). Regulationof lipolysisin adi-pocytes. Annu. Rev. Nutr. 27, 79-101.
25. Exton, J. H. (1996). Regulation of phos-phoinositide phospholipases by hormones, neurotransmitters,and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36, 481-509.
26. Feingold, K. R., Moser, A., Shigenaga, J. K., and Grunfeld, C. (2011). Inflammation inhibits GPR81 expression in adipose tissue. Inflamm. Res. 60, 991-995.
27. Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J. P., Davenport, A. P., Spedding, M., and Harmar, A. J. (2005). International union of pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57, 279-288.
28. Fredholm,B. B. (1971). The effect of lac-tate in canine subcutaneous adipose tissue in situ. Acta Physiol. Scand. 81, 110-123.
29. Ge, H., Weiszmann, J., Reagan, J. D., Gupte, J., Baribault, H., Gyuris, T., Chen,J. L.,Tian,H., and Li,Y. (2008). Elucidation of signaling and functional activities of an orphan GPCR, GPR81. J. Lipid Res. 49, 797-803.
30. Gille, A., Bodor, E. T., Ahmed, K., and Offermanns, S. (2008). Nico-tinic acid: pharmacological effects and mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 48, 79-106.
31. Gold, R. (2011). Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved. CNS Drugs 25, 37-52.
32. Hanson, J., Gille, A., Zwykiel, S., Lukasova,M., Clausen, B. E.,Ahmed, K., Tunaru, S., Wirth, A., and Offermanns, S. (2010). Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. J. Clin. Invest. 120, 2910-2919.
33. He, W., Miao, F. J., Lin, D. C., Schwand-ner, R. T., Wang, Z., Gao, J., Chen, J. L., Tian, H., and Ling, L. (2004). Citric acid cycle intermediates as lig-ands for orphan G-protein-coupled receptors. Nature 429, 188-193.
34. Hernandez, M., Wright, S. D., and Cai, T. Q. (2007). Critical role of cholesterol ester transfer protein in nico-tinic acid-mediated HDL elevation in mice. Biochem. Biophys. Res. Com-mun. 355, 1075-1080.
35. Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., and Tsujimoto, G. (2005). Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11, 90-94.
36. Hoefnagel, J. J., Thio, H. B., Willemze, R., and Bouwes Bavinck, J. N. (2003). Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br. J. Dermatol. 149, 363-369.
37. Ichimura, A., Hirasawa, A., Hara, T., and Tsujimoto, G. (2009). Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat. 89, 82-88.
38. Irukayama-Tomobe, Y., Tanaka, H., Yokomizo, T., Hashidate-Yoshida, T., Yanagisawa, M., and Sakurai, T. (2009). Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor,GPR109B. Proc. Natl. Acad. Sci. U.S.A. 106, 3930-3934.
39. Issekutz, B. Jr., and Miller, H. I. (1962). Plasma free fatty acids during exercise and the effect of lactic acid. Proc. Soc. Exp. Biol. Med. 237-239.
40. Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., and Fujino, M. (2003). Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173-176.
41. Jansson, P. A.,Larsson,A., Smith, U., and Lonnroth, P. (1994). Lactate release from the subcutaneous tissue in lean and obese men. J. Clin. Invest. 93, 240-246.
42. Jansson, P. A., Smith, U., and Lonnroth, P. (1990). Evidence for lactate production by human adipose tissue in vivo. Diabetologia 33, 253-256.
43. Jeninga, E. H., Bugge, A., Nielsen, R., Kersten, S., Hamers, N., Dani, C., Wabitsch, M., Berger, R., Stunnenberg, H. G., Man-drup, S., and Kalkhoven, E. (2009). Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81). J. Biol. Chem. 284, 26385-26393.
44. Jilek,A., Mollay, C., Tippelt, C., Grassi,J., Mignogna, G., Mullegger, J., Sander, V., Fehrer, C., Barra, D., and Kreil, G. (2005). Biosynthesis of a D-amino acid in peptide linkage by an enzyme from frog skin secretions. Proc. Natl. Acad. Sci. U.S.A. 102, 4235-4239.
45. Jones, P. M., Quinn, R., Fennessey, P. V., Tjoa, S., Goodman, S. I., Fiore, S., Burlina, A. B., Rinaldo, P., Boriack, R. L., and Bennett, M.J. (2000). Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation. Clin. Chem. 46, 149-155.
46. Kappos, L., Gold, R., Miller, D. H., Mac-manus, D. G., Havrdova, E., Limm-roth, V., Polman, C. H., Schmierer, K., Yousry, T. A., Yang, M., Erak-soy, M., Meluzinova, E., Rektor, I., Dawson, K. T., Sandrock, A. W., O'Neill, G. N., and BG-12 Phase IIb Study Investigators. (2008). Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372, 1463-1472.
47. Kostylina, G., Simon, D., Fey, M. F., Yousefi, S., and Simon, H. U. (2008). Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ. 15, 134-142.
48. Lai, E., Waters, M. G., Tata, J. R., Radziszewski, W., Perevozskaya, I., Zheng, W., Wenning, L., Connolly, D. T., Semple, G., Johnson-Levonas, A. O., Wagner, J. A., Mitchel, Y., and Paolini, J. F. (2008). Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans. J. Clin. Lipidol. 2, 375-383.
49. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., Funke, R., Gage, D., Harris, K., Heaford, A., Howland, J., Kann, L., Lehoczky, J., LeVine, R., McEwan,P.,McKernan,K.,Meldrim, J., Mesirov, J. P., Miranda, C., Morris, W., Naylor, J., Raymond, C., Rosetti, M., Santos, R., Sheridan, A., Sougnez, C., Stange-Thomann, N., Stojanovic, N., Subramanian, A., Wyman, D., Rogers, J., Sulston, J., Ainscough, R., Beck, S., Bentley, D., Burton, J., Clee, C., Carter, N., Coul-son, A., Deadman, R., Deloukas, P., Dunham, A., Dunham, I., Durbin, R., French, L., Grafham, D., Gregory, S., Hubbard, T., Humphray, S., Hunt, A., Jones, M., Lloyd, C., McMurray, A., Matthews, L., Mercer, S., Milne, S., Mullikin, J. C., Mungall, A., Plumb, R., Ross, M., Shownkeen, R., Sims, S., Waterston, R. H., Wilson, R. K., Hillier, L. W., McPher-son, J. D., Marra, M. A., Mardis, E. R., Fulton, L. A., Chinwalla, A. T., Pepin, K. H., Gish, W. R., Chissoe, S. L., Wendl, M. C., Delehaunty, K. D., Miner, T. L., Delehaunty, A., Kramer, J. B., Cook, L. L., Fulton, R. S.,Johnson, D. L., Minx, P. J., Clifton, S. W., Hawkins, T., Branscomb, E., Predki, P., Richardson, P., Wenning, S., Slezak, T., Doggett, N., Cheng, J. F., Olsen, A., Lucas, S., Elkin, C., Uberbacher, E., Frazier, M., Gibbs, R. A., Muzny, D. M., Scherer, S. E., Bouck, J. B., Sodergren, E. J., Wor-ley, K. C., Rives, C. M., Gorrell, J. H., Metzker, M. L., Naylor, S. L., Kucher-lapati, R. S., Nelson, D. L., Wein-stock, G. M., Sakaki, Y., Fujiyama, A., Hattori, M., Yada, T., Toyoda, A., Itoh, T., Kawagoe, C., Watan-abe, H., Totoki, Y., Taylor, T., Weis-senbach, J., Heilig, R., Saurin, W., Artiguenave, F., Brottier, P., Bruls, T., Pelletier, E., Robert, C., Wincker, P., Smith, D. R., Doucette-Stamm, L., Rubenfield, M., Weinstock, K., Lee, H. M., Dubois, J., Rosenthal, A., Platzer, M., Nyakatura, G., Taudien, S., Rump,A.,Yang, H.,Yu,J.,Wang, J., Huang, G., Gu, J., Hood, L., Rowen, L., Madan, A., Qin, S., Davis, R. W., Federspiel, N. A., Abola, A. P., Proctor, M. J., Myers, R. M., Schmutz, J., Dickson, M., Grimwood, J., Cox, D. R., Olson, M. V., Kaul, R., Raymond, C., Shimizu, N., Kawasaki, K., Minoshima, S., Evans,G.A.,Athana-siou, M., Schultz, R., Roe, B. A., Chen, F.,Pan,H., Ramser, J., Lehrach, H., Reinhardt, R., McCombie, W. R., de la Bastide, M., Dedhia, N., Blöcker, H., Hornischer, K., Nord-siek, G., Agarwala, R., Aravind, L., Bailey, J. A., Bateman, A., Batzoglou, S., Birney, E., Bork, P., Brown, D. G., Burge, C. B., Cerutti, L., Chen, H. C., Church, D., Clamp,M., Copley, R. R., Doerks, T., Eddy, S. R., Eichler, E. E., Furey, T. S., Galagan, J., Gilbert, J. G., Harmon, C., Hayashizaki, Y., Haus-sler, D., Hermjakob, H., Hokamp, K., Jang, W., Johnson, L. S., Jones, T. A., Kasif, S., Kaspryzk, A., Kennedy, S., Kent, W. J., Kitts, P., Koonin, E. V., Korf, I., Kulp, D., Lancet, D., Lowe, T. M., McLysaght, A., Mikkelsen, T., Moran, J. V., Mulder, N., Pollara, V. J., Ponting, C. P., Schuler, G., Schultz, J., Slater, G., Smit, A. F., Stupka, E., Szustakowski, J., Thierry-Mieg, D., Thierry-Mieg, J., Wagner, L., Wallis, J., Wheeler, R., Williams, A., Wolf, Y. I., Wolfe, K. H., Yang, S. P., Yeh, R. F., Collins, F., Guyer, M. S., Peterson, J., Felsenfeld, A., Wet-terstrand, K. A., Patrinos, A., Morgan, M. J., de Jong, P., Catanese, J. J., Osoegawa, K., Shizuya, H., Choi, S., Chen, Y. J., and International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
50. Lee, D. K., Nguyen, T., Lynch, K. R., Cheng, R., Vanti, W. B., Arkhitko, O., Lewis, T., Evans, J. F., George, S. R.and O'Dowd, B. F. (2001). Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275, 83-91.
51. Li, G., Shi, Y., Huang, H., Zhang, Y., Wu, K., Luo, J., Sun, Y., Lu, J., Benovic, J. L., and Zhou, N. (2010). Internal-ization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3. J. Biol. Chem. 285, 22605-22618.
52. Liu, C., Wu, J., Zhu, J., Kuei, C., Yu, J., Shelton, J., Sutton, S. W., Li, X., Yun, S. J., Mirzadegan, T., Mazur, C., Kamme, F., and Lovenberg, T. W. (2009). Lactate inhibits lipoly-sis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284, 2811-2822.
53. Lukasova, M., Malaval, C., Gille, A., Kero, J., and Offermanns, S. (2011). Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J. Clin. Invest. 121, 1163-1173.
54. Maciejewski-Lenoir, D., Richman, J. G., Hakak, Y., Gaidarov, I., Behan, D. P., and Connolly, D. T. (2006). Langer-hans cells release prostaglandin D2 in response to nicotinic acid. J. Invest. Dermatol. 126, 2637-2646.
55. Mandrika, I., Petrovska, R., and Klovins, J. (2010). Evidence for constitutive dimerization of niacin receptor subtypes. Biochem. Biophys. Res. Com-mun. 395, 281-287.
56. Martin, P. M., Ananth, S., Cresci, G., Roon, P., Smith, S., and Gana-pathy, V. (2009). Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Mol. Vis. 15, 362-372.
57. McKenney, J., Bays, H., Koren, M., Bal-lantyne, C. M., Paolini, J. F., Mitchel, Y., Betteridge, A., Kuznetsova, O., Sapre, A., Sisk, C. M., and Maccubbin, D. (2010). Safety of extended-release niacin/laropiprant in patients with dyslipidemia. J. Clin. Lipidol. 4, 105-112 e101.
58. Nomura, H., Nielsen, B. W., and Matsushima, K. (1993). Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int. Immunol. 5, 1239-1249.
59. Nugteren-Huying, W. M., van der Schroeff, J. G., Hermans, J., and Suurmond, D. (1990). Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J. Am. Acad. Der-matol. 22, 311-312.
60. Oberwittler, H., and Baccara-Dinet, M. (2006). Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acidtreatment. Int. J. Clin. Pract. 60, 707-715.
61. Offermanns, S., Colletti, S. L., Loven-berg, T. W., Semple, G., Wise, A., and AP, I. J. (2011). International union of basic and clinical pharmacology. LXXXII: nomenclature and classification of hydroxy-carboxylic acid receptors (GPR81, GPR109A, and GPR109B). Pharmacol. Rev. 63, 269-290.
62. Owen, O. E., Felig, P., Morgan, A. P., Wahren, J., and Cahill, G. F. Jr. (1969). Liver and kidney metabolism during prolonged starvation. J. Clin. Invest. 48, 574-583.
63. Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002). Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650.
64. Qvisth, V., Hagstrom-Toft, E., Moberg, E., Sjoberg, S., and Bolinder, J. (2007). Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women. Am. J. Physiol. Endocrinol. Metab. 292, E709-714.
65. Reich, K., Thaci, D., Mrowietz, U., Kamps, A., Neureither, M., and Luger, T. (2009). Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis-a retrospective study (FUTURE). J. Dtsch. Dermatol. Ges. 7, 603-611.
66. Richman, J. G., Kanemitsu-Parks, M., Gaidarov, I., Cameron, J. S., Griffin, P., Zheng, H., Guerra, N. C., Cham, L., Maciejewski-Lenoir, D., Behan, D. P., Boatman, D., Chen, R., Skinner, P., Ornelas, P., Waters, M. G., Wright, S. D., Semple, G., and Connolly, D. T. (2007). Nicotinic acid receptor agonists differentially activate downstream effectors. J. Biol. Chem. 282, 18028-18036.
67. Schaub, A., Futterer, A., and Pfeffer, K. (2001). PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur. J. Immunol. 31, 3714-3725.
68. Semple, G., Skinner, P. J., Cherrier, M. C., Webb, P. J., Sage, C. R., Tamura, S. Y., Chen, R., Richman, J. G., and Connolly, D. T. (2006). 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptorGPR109b.J. Med. Chem.49, 1227-1230.
69. Semple, G., Skinner, P. J., Gharbaoui, T., Shin, Y. J., Jung, J. K., Cherrier, M. C., Webb, P. J., Tamura, S. Y., Boatman, P. D., Sage,C. R., Schrader, T. O., Chen, R., Colletti, S. L., Tata, J. R., Waters, M. G., Cheng, K., Taggart, A. K., Cai, T. Q., Carballo-Jane, E., Behan, D. P., Connolly,D. T., and Richman, J. G. (2008). 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice. J. Med. Chem. 51, 5101-5108.
70. Shen, H. C., Ding, F. X., Luell, S., Forrest, M. J., Carballo-Jane, E., Wu, K. K., Wu, T. J., Cheng, K., Wilsie, L. C., Krsmanovic, M. L., Taggart, A. K., Ren, N., Cai, T. Q., Deng, Q., Chen, Q., Wang, J., Wolff, M. S., Tong, X., Holt, T. G., Waters, M. G., Hammond, M. L., Tata, J. R., and Colletti, S. L. (2007). Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor. J. Med. Chem. 50, 6303-6306.
71. Shen, H. C., Taggart, A. K., Wilsie, L. C., Waters, M. G., Hammond, M. L., Tata, J. R., and Colletti, S. L. (2008). Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A. Bioorg. Med. Chem. Lett. 18, 4948-4951.
72. Skinner, P. J., Cherrier, M. C., Webb, P. J., Sage, C. R., Dang, H. T., Pride, C. C., Chen, R., Tamura, S. Y., Rich-man, J. G., Connolly, D. T., and Semple, G. (2007). 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b. Bioorg. Med. Chem. Lett. 17, 6619-6622.
73. Skinner, P. J., Webb, P. J., Sage, C. R., Dang, T. H., Pride, C. C., Chen, R., Tamura, S. Y., Richman, J. G., Connolly, D. T., and Sem-ple, G. (2009). 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b. Bioorg. Med. Chem. Lett. 19, 4207-4209.
74. Soga, T., Kamohara, M., Takasaki, J., Matsumoto, S., Saito, T., Ohishi, T., Hiyama, H., Matsuo, A., Mat-sushime, H., and Furuichi, K. (2003). Molecular identification of nicotinic acid receptor. Biochem. Biophys. Res. Commun. 303, 364-369.
75. Stern, R. H., Spence, J. D., Freeman, D. J., and Parbtani, A. (1991). Tolerance to nicotinic acid flushing. Clin. Pharmacol. Ther. 50, 66-70.
76. Taggart, A. K., Kero, J., Gan, X., Cai, T. Q., Cheng, K., Ippolito, M., Ren, N., Kaplan, R., Wu, K., Wu, T. J., Jin, L., Liaw, C., Chen, R., Richman, J., Connolly, D., Offermanns, S., Wright, S. D., and Waters, M. G. (2005). (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nico-tinic acid receptor PUMA-G. J. Biol. Chem. 280, 26649-26652.
77. Tang, H., Lu, J. Y., Zheng, X., Yang, Y., and Reagan, J. D. (2008). The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist. Biochem. Biophys. Res. Com-mun. 375, 562-565.
78. Taylor, A. J., Sullenberger, L. E., Lee, H. J., Lee, J. K., and Grace, K. A. (2004). Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110, 3512-3517.
79. Taylor, A. J., Villines, T. C., Stanek, E. J., Devine, P. J., Griffen, L., Miller, M., Weissman, N. J., and Turco, M. (2009). Extended-release niacin or ezetimibe and carotid intima-media thickness. N. Engl. J. Med. 361, 2113-2122.
80. Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., Mellinger, J. D., Smith, S. B., Digby, G. J., Lambert, N. A., Prasad, P. D., and Ganapathy, V. (2009). GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69, 2826-2832.
81. Trudeau, F., Bernier, S., de Glisezinski, I., Crampes, F., Dulac, F., and Riviere, D. (1999). Lack of antilipolytic effect of lactate in subcutaneous abdominal adipose tissue during exercise. J. Appl. Physiol. 86, 1800-1804.
82. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K., and Offer-manns, S. (2003). PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 9, 352-355.
83. Tunaru, S., Lattig, J., Kero, J., Krause, G., and Offermanns, S. (2005). Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Mol. Pharmacol. 68, 1271-1280.
84. van Herk, T., Brussee, J., van den Nieuwendijk, A. M., van der Klein, P. A., AP, I. J., Stannek, C., Burmeis-ter, A., and Lorenzen, A. (2003).Pyrazole derivatives as partial agonists for the nicotinic acid receptor. J. Med. Chem. 46, 3945-3951.
85. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides, P., Ballew, R. M., Huson, D. H.,Wortman, J. R.,Zhang, Q., Kodira, C. D., Zheng, X. H., Chen, L., Skupski, M., Subramanian, G., Thomas, P. D., Zhang, J., Gabor Miklos, G. L., Nelson, C., Broder, S., Clark, A. G., Nadeau, J., McKu-sick, V. A., Zinder, N., Levine, A. J., Roberts, R. J., Simon, M., Slay-man, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Bid-dick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eil-beck, K., Evangelista, C., Gabrielian, A. E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T. J., Higgins, M. E., Ji,R. R., Ke, Z.,Ketchum,K.A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G. V., Mil-shina, N., Moore, H. M., Naik, A. K., Narayan,V. A.,Neelam, B.,Nusskern, D., Rusch, D. B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., Yao, A., Ye, J., Zhan, M., Zhang, W., Zhang, H., Zhao, Q., Zheng, L., Zhong, F., Zhong, W., Zhu, S., Zhao, S., Gilbert, D., Baumhueter, S., Spier, G., Carter, C., Cravchik, A., Woodage, T., Ali, F., An, H., Awe, A., Baldwin, D., Baden, H., Barnstead, M., Barrow, I., Beeson, K., Busam, D., Carver, A., Center, A., Cheng, M. L., Curry, L., Danaher, S., Davenport, L., Desilets, R., Dietz, S., Dodson, K., Doup, L., Ferriera, S., Garg, N., Gluecksmann, A., Hart, B., Haynes, J., Haynes, C., Heiner, C., Hladun, S., Hostin, D., Houck, J., Howland, T., Ibegwam, C., Johnson, J., Kalush, F., Kline, L., Koduru, S., Love, A., Mann, F., May, D., McCawley, S., McIntosh, T.,McMullen,I.,Moy,M.,Moy,L.,Mur-phy, B., Nelson, K., Pfannkoch, C., Pratts, E., Puri, V., Qureshi, H., Rear-don, M., Rodriguez, R., Rogers,Y. H., Romblad, D., Ruhfel, B., Scott, R., Sitter, C., Smallwood, M.,Stewart, E., Strong, R., Suh, E., Thomas, R., Tint, N. N., Tse, S., Vech, C., Wang, G., Wetter, J., Williams, S., Williams, M., Windsor, S., Winn-Deen, E., Wolfe, K., Zaveri, J., Zaveri, K., Abril, J. F., Guigó,R.,Campbell,M. J., Sjolander, K. V., Karlak, B., Kejariwal, A., Mi, H., Lazareva, B., Hatton, T., Narecha-nia,A., Diemer, K., Muruganujan, A., Guo, N., Sato, S., Bafna, V., Istrail, S., Lippert, R., Schwartz, R., Walenz, B., Yooseph, S., Allen, D., Basu, A., Baxendale, J., Blick, L., Caminha, M., Carnes-Stine, J., Caulk, P., Chiang, Y. H., Coyne, M., Dahlke, C., Mays, A., Dombroski, M., Donnelly, M., Ely, D., Esparham, S., Fosler, C., Gire, H., Glanowski, S., Glasser, K., Glodek, A., Gorokhov, M., Graham, K., Gropman, B., Harris, M., Heil, J., Henderson, S., Hoover, J., Jennings, D., Jordan, C., Jordan, J., Kasha, J., Kagan, L., Kraft, C., Levitsky, A., Lewis, M., Liu, X., Lopez, J., Ma, D., Majoros, W., McDaniel, J., Murphy, S., Newman, M., Nguyen, T., Nguyen, N.,Nodell, M., Pan, S., Peck, J., Peterson, M., Rowe, W., Sanders, R., Scott, J., Simpson, M., Smith, T., Sprague, A., Stockwell, T., Turner, R., Venter, E., Wang, M., Wen, M., Wu, D., Wu, M., Xia, A., Zandieh, A., and Zhu, X. (2001). The sequence of the human genome. Science 291, 1304-1351.
86. Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., and Lefkowitz, R. J. (2009). beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J. Clin. Invest. 119, 1312-1321.
87. Wang, J., Wu, X., Simonavicius, N., Tian, H., and Ling, L. (2006). Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J. Biol. Chem. 281, 34457-34464.
88. Wise, A., Foord, S. M., Fraser, N. J., Barnes, A. A., Elshourbagy, N., Eil-ert, M., Ignar, D. M., Murdock, P. R., Steplewski, K., Green, A., Brown, A. J., Dowell, S. J., Szek-eres, P. G., Hassall, D. G., Marshall, F. H., Wilson, S., and Pike, N. B. (2003). Molecular identification of high and low affinity receptors for nicotinic acid. J. Biol. Chem. 278, 9869-9874.
89. Wise, A., Jupe, S. C., and Rees, S. (2004). The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44, 43-66.
90. Yousefi, S., Cooper, P. R., Mueck, B., Potter, S. L., and Jarai, G. (2000). cDNA representational difference analysis of human neutrophils stimulated by GM-CSF. Biochem. Biophys. Res. Commun. 277, 401-409.
91. Zellner, C., Pullinger, C. R.,Aouizerat, B. E., Frost,P. H.,Kwok,P. Y., Malloy, M. J., and Kane, J. P. (2005). Variations in human HM74 (GPR109B) and HM74A (GPR109A) niacin receptors. Hum. Mutat. 25, 18-21.